IL6 and endometrial cancer: One study reported that 17β-estradiol promotes endometrial cancer proliferation and progression via activation of the IL-6 signaling pathway [11], and another revealed that OSM, a member of the IL-6 family, enhances endometrial cancer invasion and angiogenesis [12].